Daniel T. Connolly
Arena Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Angiogenesis and VEGF in Cancer, Drug Transport and Resistance Mechanisms, Diabetes Treatment and Management, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF(1989)2,071 cited
- → Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.(1989)1,271 cited
- → Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.(1990)841 cited
- → (d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G(2005)640 cited
- Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor.(1990)
- → Molecular Docking and High-Throughput Screening for Novel Inhibitors of Protein Tyrosine Phosphatase-1B(2002)466 cited
- → Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome(1994)375 cited
- → Vascular permeability factor: A unique regulator of blood vessel function(1991)318 cited
- → Human Vascular Permeability Factor(1989)286 cited
- → Binding and endocytosis of cluster glycosides by rabbit hepatocytes. Evidence for a short-circuit pathway that does not lead to degradation.(1982)221 cited